PLRX
Pliant TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The May 11 update materially improved the balance-sheet backdrop, with $172.4M in cash/investments and runway into 2H 2028, while PLN-101095 now has a visible oncology path with FORTIFY dosing and a Phase 1 response signal. That combination gives the stock optionality if the 2027 data readout broadens the early responses, but the loose peer set limits conviction.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Even after the stronger cash position, PLRX remains pre-revenue and may need additional capital if development broadens or timing slips. [#8-K-2026-05-11][#10-Q-2026-05-11]
Momentum
96
Value
58
Sentiment
97
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.70 · Bull $3.00 · Bear $0.45
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $2.50
Why
Momentum96 · Δ7d -
Value58 · Δ7d +0.2
Sentiment97 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
96
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
58
32% active weight
Current posture
7d trendFlat
Δ7d
+0.2
Δ21d
+0.2
Sentiment
97
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 95.7 / Value 57.6 / Sentiment 97.3
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$74.3M
Beta
1.39
Shares Out
61.45M
P/E (TTM) · Derived
-0.3
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.47
Rev YoY
-100.0%
EPS YoY
+55.0%
Gross Margin
-
Op Margin
-
Net Debt
-$325.51M
Current Ratio
13.93
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology